Publications: Ms Caitlin Fierheller
Fierheller C, Sarig K, Oxley S, Kalra A, Sobocan M, Sideris M, Gootzen T, Ferris M et al.
(
2024
)
.
BRCA awareness and testing experience in the UK Jewish population: A qualitative study
.
Gynecologic Oncology
.
vol.
190
,
s162
-
s163
.
Fierheller C, Gootzen T, Kalra A, Sarig K, Sobocan M, Oxley S, Dworschak N, Georgiannakis A et al.
(
2024
)
.
BRCA1 and BRCA2 information provision online: An occasion for improvement
.
Gynecologic Oncology
.
vol.
190
,
Manchanda R, Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J et al.
(
2024
)
.
Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer
.
Gynecologic Oncology
.
vol.
190
,
s159
-
s160
.
Fierheller C, Sun L, Wei X, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al.
(
2024
)
.
Population-based BRCA1 and BRCA2 genetic testing is cost-effective in Canada
.
Gynecologic Oncology
.
vol.
190
,
Kalra A, Ganesan S, Sia J, Papalois K-B, Pandya A, Xiong R, Wei X, Oxley S et al.
(
2024
)
.
EV186/#1233 Patient-related outcomes of mainstreaming genetic testing – a systematic review and meta-analysis
.
International Journal of Gynecological Cancer
.
Conference:
E-Poster Viewing Abstracts
vol.
34
,
a179
-
a180
.
Sun L, Wei X, Fierheller CT, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al.
(
2024
)
.
Economic Evaluation of Population-Based BRCA1 and BRCA2 Testing in Canada
.
JAMA Network Open
vol.
7
,
(
9
)
Manchanda R
(
2024
)
.
Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis
.
Cancers
Manchanda R, Sun L, Wei X, legood R
(
2024
)
.
Cost-effectiveness of unselected multigene germline and somatic genetic testing for epithelial ovarian cancer
.
Journal of the National Comprehensive Cancer Network : JNCCN
Oxley S, Manchanda R
(
2024
)
.
BRCA awareness and testing experience in the UK Jewish population: a qualitative study
.
Journal of Medical Genetics
Oxley S, Manchanda R
(
2024
)
.
Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D
.
Cancers
Sideris M, Brincat MR, Blyuss O, Enumula M, Cyclewala S, Oxley S, Sia J, Kalra A et al.
(
2024
)
.
1033 Validation of P-POSSUM scale in ovarian cancer (OC) cytoreductive surgery
.
Conference:
Poster and E-Postersa391.3
-
a3a392
.
Gootzen TA, Kalra A, Sarig K, Sobocan M, Oxley S, Dworschak N, Georgiannakis A, Glynou S et al.
(
2024
)
.
405 Analysis of BRCA1 and BRCA2 information provision online
.
International Journal of Gynecological Cancer
.
Conference:
Poster and E-Posters
vol.
34
,
a448
-
a449
.
Sun LI, Wei X, Fierheller CT, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al.
(
2024
)
.
406 Population-based BRCA1 and BRCA2 testing in Canada: an economic evaluation
.
International Journal of Gynecological Cancer
.
Conference:
Young Investigator Session
vol.
34
,
a52
-
a53
.
Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J, Sideris M et al.
(
2024
)
.
443 Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer
.
Conference:
Oral Sessionsa40
-
a41
.
Kalra A, Gootzen TA, Fierheller CT, Sarig K, Pan Y, Parmar A, Papalois K-B, Samuels AJ et al.
(
2024
)
.
461 HBOC and lynch syndrome: ai-powered multi-platform analysis of social media activity
.
Conference:
Poster and E-Postersa259.1
-
a2a259
.
Oxley S, Sia J, Samuels A, Kalra A, Wei X, Fierheller CT, Sideris M, Mccluggage WG et al.
(
2024
)
.
583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study
.
International Journal of Gynecological Cancer
.
Conference:
Poster and E-Posters
vol.
34
,
Oxley S, Wei X, Sideris M, Blyuss O, Kalra A, Sia J, Ganesan S, Fierheller CT et al.
(
2024
)
.
948 EQ-5D utility scores for risk-reducing mastectomy and risk-reducing salpingo-oophorectomy: mapping from SF-12 and SF-36
.
Conference:
Poster and E-Postersa460.1
-
a4a460
.
Wei X, Sun L, Slade E, Fierheller CT, Oxley S, Kalra A, Sia J, Sideris M et al.
(
2024
)
.
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer
.
JAMA Network Open
vol.
7
,
(
2
)
Wei X, Sun L, Slade E, Oxley S, Kalra A, Sia J, Sideris M, Fierheller C et al.
(
2023
)
.
EE675 Cost-Effectiveness Analysis of Cancer Susceptibility Gene-Specific Prevention and Surveillance Strategies for Ovarian and Breast Cancer
.
Value in Health
.
vol.
26
,
s183
-
s184
.
Sobocan M, Chandrasekaran D, Sideris M, Blyuss O, Fierheller C, Kalra A, Sia J, Miller RE et al.
(
2023
)
.
Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study
.
BJOG An International Journal of Obstetrics & Gynaecology
vol.
131
,
(
6
)
848
-
857
.
Alenezi WM, Fierheller CT, Serruya C, Revil T, Oros KK, Subramanian DN, Bruce J, Spiegelman D et al.
(
2023
)
.
Genetic analyses of DNA repair pathway associated genes implicate new candidate cancer predisposing genes in ancestrally defined ovarian cancer cases
.
Frontiers in Oncology
vol.
13
,
Fierheller CT, Alenezi WM, Serruya C, Revil T, Amuzu S, Bedard K, Subramanian DN, Fewings E et al.
(
2023
)
.
Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene
.
Genes
vol.
14
,
(
2
)
Alenezi WM, Milano L, Fierheller CT, Serruya C, Revil T, Oros KK, Behl S, Arcand SL et al.
(
2022
)
.
The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population
.
Cancers
vol.
14
,
(
9
)
Alenezi WM, Fierheller CT, Revil T, Serruya C, Mes-Masson A-M, Foulkes WD, Provencher D, Haffaf ZE et al.
(
2022
)
.
Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic BRCA1 Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic BRCA1 and BRCA2 Variants
.
Genes
vol.
13
,
(
4
)
Fierheller CT, Guitton-Sert L, Alenezi WM, Revil T, Oros KK, Gao Y, Bedard K, Arcand SL et al.
(
2021
)
.
A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene
.
Genome Medicine
vol.
13
,
(
1
)
Fierheller CT, Alenezi WM, Tonin PN
(
2021
)
.
The Genetic Analyses of French Canadians of Quebec Facilitate the Characterization of New Cancer Predisposing Genes Implicated in Hereditary Breast and/or Ovarian Cancer Syndrome Families
.
Cancers
vol.
13
,
(
14
)
Alenezi WM, Fierheller CT, Recio N, Tonin PN
(
2020
)
.
Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers
.
Genes
vol.
11
,
(
8
)